← Retour à la une
Asie · Marchés régionaux · Vietnam Investment Review

Bora Pharmaceuticals reports third quarter revenue and net income growth

Publié par Vietnam Investment Review · Vietnam il y a 9 h
Bora Pharmaceuticals reports third quarter revenue and net income growth
Bora Pharmaceuticals reports third quarter revenue and net income growth · Vietnam Investment Review

Résumé détaillé

Bora Pharmaceuticals announced third-quarter financial results on 13 November 2026 alongside operational updates confirming the completion of its manufacturing and biologics facilities in the United States.

HONG KONG SAR – Media OutReach Newswire – 13 November 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 3Q2026 and provides 2027 outlook update. 3Q26 Business and Financial Highlights

Bobby Sheng, Chairman of Bora Group, stated, "In 2026, customers are choosing Bora because we combine onshore North American capacity with capabilities rarely found in a network of our size. Our focus now is execution: completing these commercial technology transfers in our US facilities on time, qualifying our new isolator fill-finish capacity, where 4 PPQ batches have been completed and 3 additional technology transfer programs are scheduled for 2027, and delivering on every quality commitment we have made.

Début de l'article, extrait de Vietnam Investment Review. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur Vietnam Investment Review Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (vir.com.vn)

À lire aussi